Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

US 8980952

Methods for treating brain swelling with a compound that blocks a non-selective cation channel

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Mar 17, 2015 · Expires Mar 12, 2035

US 8961989

Methods for producing an immune response to tuberculosis

The United States of America as represented by the Department of Veteran Affairs · Granted Feb 24, 2015 · Expires Feb 19, 2035

US 8961955

Maintenance and propagation of mesenchymal stem cells

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIR · Granted Feb 24, 2015 · Expires Feb 19, 2035

US 8957015

Tumor suppressor gene p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 17, 2015 · Expires Feb 12, 2035

US 8940535

Stem cell culture medium and method of using said medium and the cells

The United States of America as Represented by the Dept. of Veterans Affairs · Granted Jan 27, 2015 · Expires Jan 22, 2035

US 8940700

E-selectin compositions and use thereof for inducing E-selectin tolerance

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jan 27, 2015 · Expires Jan 22, 2035

US 8926986

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

US 8927030

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

US 8926987

Replication-competent adenoviral vectors

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 6, 2015 · Expires Jan 1, 2035

US 8921071

Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 30, 2014 · Expires Dec 25, 2034

US 8911742

Transcutaneous immunization without heterologous adjuvant

The United States of America as represented by the Secretary of the Army · Granted Dec 16, 2014 · Expires Dec 11, 2034

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

US 8906358

Leishmania challenge model

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 9, 2014 · Expires Dec 4, 2034

US 8901093

Custom vectors for treating and preventing pancreatic cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 2, 2014 · Expires Nov 27, 2034

US 8895521

Methods and compositions for the treatment of uveitis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 25, 2014 · Expires Nov 20, 2034

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

The United States of America as represented by the Department of Veteran Affairs · Granted Nov 25, 2014 · Expires Nov 20, 2034

US 8877199

B cell surface reactive antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 4, 2014 · Expires Oct 30, 2034

US 8871191

Use of IL-15 preparations to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

US 8865686

Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitors

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

US 8865880

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 21, 2014 · Expires Oct 16, 2034

US 8858930

Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle

The United States of America as represented by the Department of Veteran Affairs · Granted Oct 14, 2014 · Expires Oct 9, 2034

US 8858946

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 14, 2014 · Expires Oct 9, 2034